Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab vs Mycophenolate Mofetil in Steroid Dependent Non-infectious Uveitis
NCT06258915Phase 3Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2024
- Primary completion
- Jun 2027
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of adalimumab in noninfectious uveitis (NIU), sponsored by Assistance publique - Hôpitaux de Paris. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
03
Conditions
noninfectious uveitis (NIU)
Beyond the preview
Go deeper on NCT06258915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06258915.